178 related articles for article (PubMed ID: 21162783)
1. [Clinical significance of virulence-related genes of type III secretion system of Pseudomonas aeruginosa].
Zhuo C; Wang LX; Xiao SN; Li HY; Qiu GX; Zhong NS
Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):354-9. PubMed ID: 21162783
[TBL] [Abstract][Full Text] [Related]
2. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
Zhao RZ; Zheng YJ; Chen Q
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816
[TBL] [Abstract][Full Text] [Related]
3. [Research of differential expression of virulence-related proteins of T3SS in Pseudomonas aeruginosa].
Li XQ; Zhuo C; Liao DJ; Xiao SN; Jin GY; Zhong NS
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):849-52. PubMed ID: 20450627
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
Berthelot P; Attree I; Plésiat P; Chabert J; de Bentzmann S; Pozzetto B; Grattard F;
J Infect Dis; 2003 Aug; 188(4):512-8. PubMed ID: 12898437
[TBL] [Abstract][Full Text] [Related]
5. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
[TBL] [Abstract][Full Text] [Related]
6. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
7. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the drug-resistance of Pseudomonas aeruginosa and the use of antibiotics in burn wards].
Dou Y; Zhang X; Zhang Q; Shi Y
Zhonghua Shao Shang Za Zhi; 2011 Apr; 27(2):109-13. PubMed ID: 21651847
[TBL] [Abstract][Full Text] [Related]
9. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit.
Ozer B; Duran N; Onlen Y; Savas L
J Antibiot (Tokyo); 2012 Jan; 65(1):9-13. PubMed ID: 22086166
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
11. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis.
Zhu H; Conibear TC; Bandara R; Aliwarga Y; Stapleton F; Willcox MD
Curr Eye Res; 2006 Apr; 31(4):297-306. PubMed ID: 16603462
[TBL] [Abstract][Full Text] [Related]
12. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
13. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.
Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M
BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938
[TBL] [Abstract][Full Text] [Related]
14. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
[TBL] [Abstract][Full Text] [Related]
15. The role of type III secretion system and lens material on adhesion of Pseudomonas aeruginosa to contact lenses.
Shen EP; Tsay RY; Chia JS; Wu S; Lee JW; Hu FR
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6416-26. PubMed ID: 22918630
[TBL] [Abstract][Full Text] [Related]
16. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines.
Stepińska M; Trafny EA
Microb Pathog; 2008 May; 44(5):448-58. PubMed ID: 18221854
[TBL] [Abstract][Full Text] [Related]
17. Relative expression of Pseudomonas aeruginosa virulence genes analyzed by a real time RT-PCR method during lung infection in rats.
Joly B; Pierre M; Auvin S; Colin F; Gottrand F; Guery B; Husson MO
FEMS Microbiol Lett; 2005 Feb; 243(1):271-8. PubMed ID: 15668029
[TBL] [Abstract][Full Text] [Related]
18. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
[TBL] [Abstract][Full Text] [Related]
19. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
[TBL] [Abstract][Full Text] [Related]
20. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
